
Sinride PM 2mg/500mg/15mg Tablet SR
Marketer
Indoscot Healthcare LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sinride PM 2mg/500mg/15mg Tablet SR
GlucoTrim PM 2mg/500mg/15mg Extended-Release Tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin utilization, consequently reducing blood sugar. Dosage and frequency of GlucoTrim PM should strictly adhere to your physician's instructions. Administer with food to mitigate potential gastrointestinal distress. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular regimen. Never double the dose. Excessive intake may result in hypoglycemia. Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals can increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal discomfort, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function assessment will be performed before treatment initiation. Limit alcohol consumption to minimize the likelihood of side effects.
Primary Ingredients of Sinride PM 2mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Sinride PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sinride PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sinride PM 2mg/500mg/15mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. It should be administered with a meal.
Common Side effects of Sinride PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sinride PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Sinride PM 2mg/500mg/15mg sustained-release tablet should be taken with a meal.
How Sinride PM 2mg/500mg/15mg Tablet SR works:
Sinride PM SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sinride PM 2mg/500mg/15mg SR tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Sinride PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sinride PM 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Sinride PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sinride PM 2mg/500mg/15mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Sinride PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sinride PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Sinride PM 2mg/500mg/15mg Tablet SR :
Should you forget to take a Sinride PM 2mg/500mg/15mg SR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sinride PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
